http://www.aduro.com
Aduro Biotech, Inc. Company Intro
Aduro is a clinical-stage cancer immunotherapy company with multiple therapeutic approaches in development that have the potential to yield powerful immunotherapy combinations.
Industry
Healthcare
Aduro Biotech, Inc. Headquaters
740 Heinz Avenue
Berkeley,94710-2224
United States
Aduro Biotech, Inc. Share price
14 Sep 2022 08:32 GMT
$0
0.0 (0 %)
Aduro Biotech, Inc. Market cap
$
WMC RANKING
2022
Aduro Biotech, Inc. # 143
BiotechnologyLatest Aduro Biotech, Inc. News
30 Nov 2022
Johnson & Johnson Names CEO Joaquin Duato as Chairman ...
Janssen Biotech, Inc. (Janssen), Aduro's license partner for ADU-214, is conducting the global trial. As quoted in the press release:.
28 Nov 2022
Cancer Vaccines Market Size, Share, Growth, Trends ...
Key Players Analysis : CSL Limited, ADURO BIOTECH INC., Astellas Pharma Inc., Merck & Co., Inc., Sanofi, Bristol-Myers Squibb Company, Glaxosmithkline Plc.,...
WMC Market Score
WMC Market to Revenue Score
Aduro Biotech, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Aduro Biotech, Inc. | USD | $27,270 | $100,319 | $-66,520 | $ | 143 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Aduro Biotech, Inc. Social Followers vs Top 4 Industry Competitors
Aduro Biotech, Inc. Post vs Top 4 Industry Competitors
Aduro Biotech, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Aduro Biotech, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Aduro Biotech, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Aduro Biotech, Inc. | 0.30 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 33 | 0 | 0 | 14.66 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
